EAN 2020 | Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?
Paola Barbarino
Paola Barbarino, CEO, Alzheimer’s Disease International, outlines the challenges to prepare healthcare systems for the diagnosis, treatment, and care of Alzheimer’s disease in a future with disease-modifying therapies. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
Related videos
5:16
Post-COVID-19 dementia landscape
Paola Barbarino
5:11
Mild cognitive impairment: biomarker counseling, diagnosis and follow-up
Kristian Steen Frederiksen
4:20
Dementia care during the COVID-19 pandemic
Paola Barbarino
2:23
Metabolic deficits and neuropsychological changes in Alzheimer's disease
Simon Bell
5:21
Diagnosing mild cognitive impairment
Kristian Steen Frederiksen
